ACST — Acasti Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Acasti Pharma, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	R2019 March 31st	C2020 March 31st	2021 March 31st	C2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	25.8	14.2	60.7	43.7	27.9
Net Total Accounts Receivable
Net Total Receivables	1.19	0.546	0.53	0.548	0.802
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28	18.5	62.4	45.3	29.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.11	0.147	0.086	0.565	0.567
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	36.9	22.9	62.5	129	79.1
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.7	7.39	1.58	3.26	3.41
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	25.9	9.86	6.8	20.4	11.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	11	13	55.7	108	68
Total Liabilities & Shareholders' Equity	36.9	22.9	62.5	129	79.1
Total Common Shares Outstanding